We describe here a typical case of virilizing adrenocortical tumor. A 23-year-old Japanese woman had her male-like musculature, hirsutism, the absence of breast development and marked clitoromegaly. Adrenal androgens were remarkably elevated, with plasma dehydroepiandrosterone sulfate 2,752 Jig/dl, plasma testosterone 250 ng/dl and urinary 17-ketosteroids 203.4 mg/day. A well-encapsulated tumor approximately 7 cm in diameter was detected in the left adrenal gland by computed tomography, magnetic resonance imaging and arteriography.
Introduction
The vast majority of cases offemale pseudohermaphroditism reported in Japan are caused by congenital adrenal hyperplasia, but a small percentage (3.6%) are caused by an androgenproducing adrenal tumor (1) . Seventy-five percent of such tumors are malignant (2) , and thus a benign virilizing adrenal tumor is rather unusual. We describe here a typical case of virilizing adrenocortical tumor without apparent histological evidence of malignancy.
Case Report
A 23-year-old Japanese womenwasadmitted to our hospital in April 1993, with the complaint of the absence of breast development. The patient's menstrual cycle had been irregular since menarche at age 1 1. She began to notice the appearance of a deep voice and the presence of excess body hair at age 12, as well as the growing of a sparse beard at age 14. The beard gradually became heavy and necessitated shaving every day at age20.
On physical examination the patient showed male-like musculature with undeveloped breasts (Fig. 1A) . The circadian rhythms of plasma ACTH and cortisol levels were normal, showing declines during a nocturnal period.
and 459 pg/ml, respectively, by the combined stimulation of compulsive intravascular dehydration by an intravenous injection of 40 mg furosemide and 2 hours upright standing. Dexamethasone failed to suppress plasma DHEA-S or urinary 17-KS at doses of 2 and 8 mg/day, whereas it strongly suppressed plasma cortisol at both concentrations ( Table 1 ). The circadian rhythms of plasma adrenocorticotropic hormone (ACTH) and cortisol were preserved, as shown by declines in t heir levels during a nocturnal period (Table 2 ). An abdominal computed tomographic (CT) scan revealed a round tumor of approximately 7 cm in diameter in the left adrenal region. Low density areas were visible inside the tumor ( Fig. 2A) . Magnetic resonance imaging (MRI) of the tumor exhibited a slightly low signal on a T{-weighted image and a high signal on a T2-weighted image (Fig. 2B ). Adrenal scintigraphy with 13 1I-adosterol revealed a diffuse uptake of the radioactive agent by the tumor. The right adrenal gland also strongly uptook the agent and was thought to have a normal function (Fig. 2C ). Abdominal arteriography demonstrated that the tumor was fed by the left upper adrenal artery, confirming the adrenal origin of the tumor (Fig. 2D ).
On the basis of the clinical features as well as the endocrinological and radiological findings, a left virilizing adrenocortical tumor was diagnosed and surgically resected in May 1993. The tumor was well-encapsulated without any invasion of the surrounding tissue, and easily removed from the abdominal lumen.
The resected tumor was yellowish brown, 8x8x4 cmlarge and weighed 400 g. Its cut surface contained areas ofnecrosis and hemorrhage (Fig. 3A) . Histologically, the cells were compact and predominantly eosinophilic with ovoid vesicular nuclei, and were arranged in either a trabecular pattern or solid sheets. Neither extension beyond the adrenal capsule nor mitotic figures of the nuclei were observed microscopically, being compatible with the diagnosis of a benign adrenocortical adenoma (Figs. 3B and C). One month after surgery, adrenal androgens became normal, with DHEA 258 ng/dl, DHEA-S 158 jag/dl, androsterone 0.2 ng/ml, testosterone 10 ng/dl and urinary 17-KS 4.7 mg/day.
The patient began to notice the disappearance of hirsutism 3 months after the operation. Neither re-elevation of adrenal androgens nor recurrence of the tumor on CT films has been observed during 9 months' followup at our outpatient clinic. have been reported to secrete sufficient levels ofglucocorticoids into the circulating blood to induce Cushing's syndrome (5) . Contrary to the typical elevation of plasma levels of both DHEA and DHEA-S in the present patient, neither clinical features nor hormonal abnormalities characteristic of glucocorticoid excess were found: both basal levels and circadian rhythms of plasma ACTH and cortisol were normal, and plasma cortisol levels were suppressed by a small dose of dexamethasone, indicating a normal ACTH-glucocorticoid axis. In the present case, the plasma aldosterone level was moderately elevated. Since neither plasma deoxycorticosterone nor corticosterone, both aldosterone precursors, increased, it is unlikely that the high aldosterone level was due to excess production by the tumor itself. Elevated plasma renin activity (PRA) was probably responsible for this high aldosterone level in the patient, since a dependency of aldosterone secretion on PRA was demonstrated by the test of compulsive intravascular Sakumaet al dehydration.
Seventy-five percent of virilizing adrenocortical tumors reported in Japan were malignant according to a literature search from 1968 to 1986 by Nakagawa et al (2) . Preoperative evaluation of the nature of the adrenal mass is important, since the prognosis of malignant adrenocortical tumors is poor, with overall median and five-year survival rates of 14 months and 24%, respectively (9). In general, early and complete demonstration of tumor involvement by imaging modalities, such as CT, MRI and arteriography, allows accurate assessment of tumor extension and subsequent complete surgical removal (10, 1 1) . When a tumor is apparently confined to the adrenal gland without any dissemination to other organs, the criterion ofa mass larger than 6 cm is considered to be the most positive predictor of malignancy (3). Copeland (8) reported that adenomas larger than 6 cm in diameter were rare (3 in 12,000 autopsies), whereas most adrenocortical carcinomas (105 of 1 14) were over 6 cm in diameter. However, the size of an adrenal mass as an indicator of malignancy or benign status is still the subject of c ontroversy (12, 13 
